Table 5.4.2Compliance (mean hr/night) in randomized controlled trials of autoCPAP vs. CPAP

Study
PMID
Baseline AHI (SD) [eligibility]Baseline ESS (SD)Duration (design)InterventionsNo. AnalyzedBaseline (SD)Change (final)Net diff or diffP BtwDropout, %Study Quality
Damjanovic 2009174
19129293
44 (25) [≥15]8.8 (5.2)3 mo (PL)autoCPAP465.40−0.7, 0.7nd8B
CPAP465.4
9 mo (PL)autoCPAP345.20.1−0.9, 1.1nd22
CPAP445.1
Meurice 2007177
17638595
55 (10) [nd]11.8 (4.9)3 mo (PL)autoCPAP (AutoSet)156.0−0.1−0.786, 0.586nd15B
CPAP146.1
6 mo (PL)autoCPAP (AutoSet)156.1−0.4−1.28, 0.48nd15
CPAP146.5
Patruno 2007180
17494789
46 (14) [>20]15 (2.7)3 mo (PL)autoCPAP156.20.2−0.25, 0.65nd23C
CPAP166.0
Planes 2003193
12683473
59 (17) [≥30]15.1 (3.9)2 mo (PL)autoCPAP164.5−0.8ndNS14C
CPAP145.3
Series 1997191
9341056
44 (20) [nd]15.5 (4.5)0.75 mo (PL)autoCPAP est.12nd *--NS0C
CPAP12nd
autoCPAP meas.12nd --NS
CPAP12nd
Fietze 2007175
17337881
42 (26) [≥10]nd1.5 mo (PL)autoCPAP205.00.8ndNS0C
CPAP214.2
Resta 2004188
15679008
47 (11) [>30]13.9 (3.2)1 mo (PL)autoCPAP105.2−0.1−1.12, 0.92nd0C
CPAP105.3
Vennelle 2010194
20175411
33 (18) [≥15]14 (3)6 wk (XO)autoCPAP1814.20.20.003, 0.3970.0479.5A
CPAP1814.0
Hukins 2004183
15683142
56 (nd)12.5 (nd)1–2 mo (XO)autoCPAP465.050.19−0.062, 0.442 0.1416B
CPAP464.86
Randerath 2001190
11254519
35 (26) [≥10]11.1 (5.1)1.5 mo (XO)autoCPAP52 (46?)5.260−0.44, 0.44nd12B
CPAP52 (46?)5.26
Massie 2003186
12406840
nd [≥15]nd1.5 mo (XO)autoCPAP445.10.580.18, 0.99 §0.0054B
CPAP444.52
To 2008181
18197915
54 (nd) [>30]13.4 (nd)1 mo (XO)autoCPAP414.30.50.02, 0.98 **0.045B
CPAP413.8
2 mo (XO)autoCPAP414.40.70.17, 1.23 ††0.01
CPAP413.7
Nussbaumer 2006179
16537862
41 (20) [>10]12.7 (3.3)1 mo (XO)autoCPAP305.10.3−0.29, 0.89nd12B
CPAP304.8
Senn 2003189
Switzerland 14525804
46 (23) [>10]14.2 (3.8)1 mo (XO)autoCPAP (Autoset T)295.5−0.1ndNS7B
autoCPAP (AutoAdjust)295.5−0.1ndNS
CPAP295.6
Nolan 2007178
17326544
15 (8) [≥5)12.3 (4.0)2 mo (XO)autoCPAP294.90nd0.9415B
CPAP294.9
Noseda 2004187
15249439
51 (25) [>20]10.7 (2.4)2 mo (XO)autoCPAP245.3−0.2−0.89, 0.49nd11B
CPAP245.5
Hudgel 2000182
10947032
30 (25) [nd]16.0 (5.0)3 mo (XO)autoCPAP146.00.50.02, 0.98 ‡‡<0.0435C
CPAP195.5
Marrone 2004185
15165530
68 (12) [30]16.3 (5.0)1 mo (XO)autoCPAP224.90.5−0.26, 1.26nd0C
CPAP224.4
Galetke 2008176
17148931
33 (19) [>10]10.3 (5.7)2 mo (XO)autoCPAP206.37−0.01−0.82, 0.8nd0?C
CPAP206.38
Hussain 2004184
15072173
47 (36) [>15]11.1 (6.4)1 mo (XO)autoCPAP104.30.6−0.84, 2.04nd0C
CPAP103.7
Teschler 2000192
10885414
53 (26) [>20]nd2 mo (XO)autoCPAP106.30.2−0.7, 1.1nd0?C
CPAP106.1
*

directions of changes were not reported in the study

directions of changes were not reported in the study

Estimated from reported P value

§

Estimated from reported P value

**

Estimated from reported P value

††

Estimated from reported P value

‡‡

Estimated from reported P value

From: Appendix D, Summary Tables

Cover of Diagnosis and Treatment of Obstructive Sleep Apnea in Adults
Diagnosis and Treatment of Obstructive Sleep Apnea in Adults [Internet].
Comparative Effectiveness Reviews, No. 32.
Balk EM, Moorthy D, Obadan NO, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.